The effects of yogurt with isomer enriched conjugated linoleic acid on insulin resistance in obese adolescents;Efectos del yogur enriquecido con isómeros del ácido linoleico conjugado, sobre resistencia a la insulina en adolescentes obesos

Revista Espanola de Pediatria

Volumn 64, Issue 1, 2008, Pages 94-100

  Bonet Serra, B ^a,b   Quintanar Rioja, A ^a   Viana Arribas, M ^b   Iglesias Gutierrez E ^c   Varela Moreiras, G ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

^c NONE

Author keywords

Conjugated linoleic acid; Diabetes; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CONJUGATED LINOLEIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; PLACEBO; YOGHURT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; SCHOOL CHILD;

EID: 42249096111     PISSN: 0034947X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S & Bazzarre T, et al. (2002) Cardiovascular health in childhood. A statement for health professionals from the committee on atherosclerosis, hypertension and obesity in the young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106: 143-60.
2. Ogden CL, Carroll LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
3. Mossberg HO. 40-Year follow-up of overweight children. Lancet 1989; 8661: 491-3.
4. Must A, Jacques PF, Dallal GE, Bajema CJ. Dietz W. Long-Term morbidity and mortality of overweight adolescents. A Follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-5.
5. Young TK, Dean HJ, Flett B, Wood-Steiman P. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr 2000; 136: 365-9.
6. Bonet B, Viana M, Sánchez-Vera I, Quintanar A, Martínez JA, Espino M. Adipose tissue and liver lipid metabolism in obese children: role of the body mass index and the presence of acanthosis nigricans. Diabet Med 2007; 24: 1192-8.
7. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2000; 346: 802-10.
8. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular Risk in children. Circulation 2003; 107: 1448-53.
9. Belury MA. Dietary Conjugated Linoleic Acid in Health: Physiological Effects and Mechanisms of Action. Annu Rev Nut 2002; 22: 505-31.
10. Aminot-Gilchrist DV, Anderson HDI. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Am J Clin Nutr 2004; 79 (Suppl.): 1159S-63S.
11. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002; 88: 243-51.
12. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. A potential link to fatty acid-induced insulin resistance. Circulation 2002; 106: 1925-9.
13. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10 cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25: 1516-21.
14. Bonet B, Quintanar A, Sentchordi L, Lindo D, Pérez-Lescure J, Martínez J. Group therapy for the treatment of obesity in children and adolescents. An Pediatr 2007; 67: 49-54.
15. Hernández M, Castellet J, García M, et al. Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo. Fundación Faustino Orbegozo. Madrid: Ed. Garsi; 1988. p. 117-50.
16. Serra L, Aranceta J. Alimentación infantil y juvenil. Estudio enKid. Barcelona: Masson, S.A.; 2002.
17. Ministry of Agriculture, Fisheries and Food. Food portion sizes. London: The Stationery Office; 1999.
18. Serra L, Román B, Aranceta J. Actividad física y salud. Estudio en Kid. Barcelona: Masson, S.A.; 2006.
19. Mattews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
20. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453-8.
21. Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest 2006; 116: 1813-22.
22. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation 2002; 105: 2923-8.
23. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238-44.
24. Vessby B, Tengblad S, Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994; 37: 1044-50.
25. Folsom AR, Ma J, McGovern PG, Eckfeldt H. Relation between plasma phospholipids saturated fatty acids and hyperinsulinemia. Metabolism 1996; 45: 223-8.
26. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 34: 1343-50.
27. Larsen JJS, Dela F, Kjaer M, Galbo H. The effect of moderate exercise on postprandial glucose homeostasis in NIIDM patients. Diabetologia 1997; 40: 447-53.
28. Yamanouchi K, Shinozaki T, Chikada K, et al. Daily walking combined with diet therapy is a useful means for obese NIIDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 1995; 18: 775-8.
29. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O (2005). Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135: 778-84.
30. Laso N, Brugue E, Vidal J, Ros E, Arnaiz JA, Carn X, Vidal S, Mas S, Deulofeu R, Lafuente A. Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components. Br J Nutr 2007; 98: 860-8.